Comparison of three standard neoadjuvant chemotherapy regimens based on pathological tumor response in breast cancer patients

Author unknown

Open source

DOI
10.36721/pjps.2022.35.1.reg.129-133.1
Published
2022-01-01
Container
Pakistan Journal of Pharmaceutical Sciences
Publisher
Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi
Open access
unknown

Credibility signals

uncertain Score 58/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.36721/pjps.2022.35.1.reg.129-133.1,
  title = {Comparison of three standard neoadjuvant chemotherapy regimens based on pathological tumor response in breast cancer patients},
  year = {2022},
  journal = {Pakistan Journal of Pharmaceutical Sciences},
  doi = {10.36721/pjps.2022.35.1.reg.129-133.1},
  url = {https://doi.org/10.36721/pjps.2022.35.1.reg.129-133.1}
}

RIS

TY  - JOUR
TI  - Comparison of three standard neoadjuvant chemotherapy regimens based on pathological tumor response in breast cancer patients
PY  - 2022
JO  - Pakistan Journal of Pharmaceutical Sciences
DO  - 10.36721/pjps.2022.35.1.reg.129-133.1
UR  - https://doi.org/10.36721/pjps.2022.35.1.reg.129-133.1
ER  - 

APA

Comparison of three standard neoadjuvant chemotherapy regimens based on pathological tumor response in breast cancer patients. (2022). Pakistan Journal of Pharmaceutical Sciences. https://doi.org/10.36721/pjps.2022.35.1.reg.129-133.1

Source records